中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

急、慢性药物性肝损伤临床特征的对比分析

纪童童 陆海英 谭宁 于岩岩 徐小元

引用本文:
Citation:

急、慢性药物性肝损伤临床特征的对比分析

DOI: 10.3969/j.issn.1001-5256.2020.07.021
基金项目: 

国家十三五科技重大专项资助项目(2018ZX10725506-001); 

详细信息
  • 中图分类号: R575

A comparative analysis of the clinical features of acute and chronic drug-induced liver injury

Research funding: 

 

  • 摘要:

    目的回顾性对比分析急、慢性药物性肝损伤(DILI)临床特征的异同。方法收集2015年1月-2018年12月在北京大学第一医院感染疾病科诊断为DILl的183例住院患者的临床资料,分为急性组(n=138)和慢性组(n=45)。收集患者基本情况、基础疾病、可疑药物用药史、过敏史、饮酒史、症状体征、实验室检查、影像学检查、肝组织病理检查、治疗、转归等资料。所有诊断为DILI的患者均进行RUCAM、肝损伤类型及严重程度分级评分。符合正态分布的计量资料2组间比较采用t检验,不符合正态分布的计量资料2组间比较采用Mann-Whitney U检验;计数资料2组间比较采用χ2检验; DILI慢性化的影响因素分析采用logistics回归分析。结果中草药导致DILI在急、慢性组的病例数为105 (76. 1%)和33 (73. 3%),抗菌素所致的为15 (10. 9%)和5(11. 1%)。2组患者性别(χ2=4. 774,P=0. 029)、肝损伤类型(χ2=9. 848,P=0. 020)及DILI严重程度分级(χ2=8. 012,P=0. 046)情况比较差异均有统计学意义;慢性组RUCAM评分...

     

  • [1]Drug-induced Liver Disease Study Group,Chinese Society of Hepatology,Chinese Medical Association.Guidelines for the management of drug-induced liver injury[J].J Clin Hepato1,2015,31(11):1752-1769.(in Chinese)中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志,2015,31(11):1752-1769.
    [2]LIANG S,FAN ZP,NIE W,et al.Clinical types and features of chronicity of drug-induced liver injury[J].J Clin Hepatol,2016,32(12):2356-2359.(in Chinese)梁珊,范作鹏,聂巍,等.药物性肝损伤慢性化的临床类型及特点[J].临床肝胆病杂志,2016,32(12):2356-2359.
    [3]HAYASHI PH,FONl-ANA RJ.Clinical featuresdiagnosis and natural history of drug-induced liver injury[J].Semin Liver Dis,2014,34(2):134-144.
    [4]XU QL,HE LL,LI C,et al.A clinical study of 516 cases of druginduced liver injury[J].J Bethune Med Sci,2019,17(3):223-225.(in Chinese)徐庆玲,何兰兰,李纯,等.516例药物性肝损伤的临床研究[J].白求恩医学杂志,2019,17(3):223-225.
    [5]ZHU CW,WANG HN,YUAN JL,et al.Clinical features of druginduced liver injury:An analysis of 445 cases[J].J Clin Hepatol,2018,34(2):354-358.(in Chinese)朱春雾,王海南,袁继丽,等.445例药物性肝损伤的临床分析[J].临床肝胆病杂志,2018,34(2):354-358.
    [6] MIAO XH.Mechanism of drug-induced liver injury[M]//CHENCW.Drug-induced and toxic liver disease.Shanghai:Shanghai Scientific&Technical Publishers,2002:130-242.(in Chinese)缪晓辉.药物性肝损害机制[M]//陈成伟.中毒与药物性肝病.上海:上海科技出版社,2002:130-242.
    [7]HUANG CY,LIU YM,HUANG YL,et al.Drug-induced liver injury accompanied by autoimmune phenomena:An analysis of clinical characteristics[J].J Clin Hepatol,2015,31(8):1303-1306.(in Chinese)黄春洋,刘燕敏,黄云丽,等.药物性肝损伤患者伴自身免疫现象的临床特点分析[J].临床肝胆病杂志,2015,31(8):1303-1306.
    [8]YANG J,YU YL,JIN Y,et a I.Clinica I characteristics of drug-induced liver injury and primary biliary cirrhosis[J].World J Gastroenterol,2016,22(33):7579-7586.
    [9]JIANG HL,QI YB,ZHANG R,et al.Detection rates of autoantibodies in patients with drug-induced liver injury and their clinical significance[J].J Clin Hepatol,2018,34(1):164-167.(in Chinese)姜红丽,祁亚宾,张睿,等.药物性肝损伤患者自身抗体的检出率及其临床意义[J].临床肝胆病杂志,2018,34(1):164-167.
    [10]LICATA A,MAIDA M,CABIBI D,et al.Clinical features and outcomes of patients with drug-induced autoimmune hepatitis:A retrospective cohort study[J].Dig Liver Dis,2014,46(12):1116-1120.
    [11]OH HJ,MOK YM,BAEK MS,et a I.Co-development of autoimmune hepatitis and Sj9gren's syndrome triggered by the administration of herbalmedicines[J].Clin Mol Hepatol,2013,19(3):305-308.
    [12]BJORNSSON E,TALWALKAR J,TREEPRASERTSUK S,et al.Drug-induced autoimmune hepatitis:Clinical characteristics and prognosis[J].Hepatology,2010,51(6):2040-2048.
    [13]CASTIELLA A,LUCENA MI,ZAPATA EM,et al.Drug-induced autoimmune-like hepatitis:A diagnostic challenge[J].Dig Dis Sci,2011,56(8):2501-2502.
    [14]LI FL,HUANG ZG,GE CL,et al.Logistic regression analysis of the clinical characteristics and prognostic factors of drug-induced liver injury[J].J Hepatobiliary Surg,2019,27(4):258-262.(in Chinese)李飞龙,黄赵刚,葛朝亮,等.药物性肝损伤的临床特点及预后因素Logistic回归分析[J].肝胆外科杂志,2019,27(4):258-262.
    [15]ZHANG XY,CHEN HQ,BAI C,et al.Clinical characteristics and prognosis of drug-induced liver injury[J].Contemp Med,2019,25(7):137-139.(in Chinese)张旭艳,陈慧群,白成.药物性肝损伤的临床特点及其预后评估[J].当代医学,2019,25(7):137-139.
  • 加载中
计量
  • 文章访问数:  1402
  • HTML全文浏览量:  58
  • PDF下载量:  724
  • 被引次数: 0
出版历程
  • 出版日期:  2020-07-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回